Floatz logo

CLOMIPHENE CITRATE

Hyperprolactinemia

Xiyuan Hospital of China Academy of Chinese Medical SciencesSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Hyperprolactinemia cohort.

Asset / SponsorPhaseRating
Paliperidone Palmitate 3-Month Formulation
Si Tianmei
Phase 4BB
Cipralex
Si Tianmei
Phase 4BB
Risperdal
Si Tianmei
Phase 4BB
CITALOPRAM
Si Tianmei
Phase 4BB
Sertraline
Si Tianmei
Phase 4BB

View all 11 →

Same molecule, other indications

CLOMIPHENE CITRATE is also rated in:

infertility disorderDormant
A
Indicative ·
81 / 100
View asset →
anovulationDormant
BBB
Indicative ·
79 / 100
View asset →
polycystic ovary syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →